{"transactions":[{"id":4622583,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-09-18T12:30:23.000Z","date":"2026-09-17","kind":"purchase","planned":false,"acquired":true,"shares":24000,"price":0.208,"value":4992.0,"ownership":{"direct":true},"balance_after":126822,"source":{"system":"sec-edgar","filing":"0001493152-26-043246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450324/000149315226043246/ownership.xml","form_type":"4"}},{"id":4620654,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-09-17T16:01:18.000Z","date":"2026-09-16","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":0.21,"value":2310.0,"ownership":{"direct":true},"balance_after":102822,"source":{"system":"sec-edgar","filing":"0001493152-26-043073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450324/000149315226043073/ownership.xml","form_type":"4"}},{"id":4618943,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-09-16T13:15:22.000Z","date":"2026-09-15","kind":"purchase","planned":false,"acquired":true,"shares":22000,"price":0.221,"value":4862.0,"ownership":{"direct":true},"balance_after":91822,"source":{"system":"sec-edgar","filing":"0001493152-26-042848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450324/000149315226042848/ownership.xml","form_type":"4"}},{"id":4618137,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:44.000Z","date":"2026-09-14","kind":"purchase","planned":false,"acquired":true,"shares":5900,"price":0.219,"value":1292.1,"ownership":{"direct":true},"balance_after":69822,"source":{"system":"sec-edgar","filing":"0001493152-26-042754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450324/000149315226042754/ownership.xml","form_type":"4"}},{"id":842554,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Series G Convertible Preferred Stock","published_at":"2026-03-16T21:30:41.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":25,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole perferred share, effectively $1.00 per share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole perferred share, effectively $1.00 per share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"None"}],"balance_after":0,"derivative":{"exercise_date":"2026-03-06","underlying":"common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-010334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226010334/ownership.xml","form_type":"4"}},{"id":842553,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common stock","published_at":"2026-03-16T21:30:41.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63922,"source":{"system":"sec-edgar","filing":"0001493152-26-010334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226010334/ownership.xml","form_type":"4"}},{"id":851987,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Class G Warrants","published_at":"2026-03-10T21:56:40.000Z","date":"2026-03-06","kind":"other","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each warrant is exercisable for one share of common stock at an exercise price of $1.00 per share and was issued as part of a subscription right issued in a rights offering."}],"balance_after":50000,"derivative":{"exercise_price":1,"exercise_date":"2026-03-06","expiration_date":"2031-03-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-009587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226009587/ownership.xml","form_type":"4"}},{"id":851986,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Series G Convertible Preferred Stock","published_at":"2026-03-10T21:56:40.000Z","date":"2026-03-06","kind":"other","planned":false,"acquired":true,"shares":25,"price":25000,"value":625000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 1,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"n/a - Preferred shares are perpetual."}],"balance_after":25,"derivative":{"exercise_price":1000,"exercise_date":"2026-03-06","expiration_date":"2050-03-06","underlying":"Series G Convertible Preferred Stock","underlying_shares":25},"source":{"system":"sec-edgar","filing":"0001493152-26-009587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226009587/ownership.xml","form_type":"4"}},{"id":1110399,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-06-16T14:53:28.000Z","date":"2025-06-13","kind":"purchase","planned":false,"acquired":true,"shares":107,"price":7.697,"value":823.579,"ownership":{"direct":true},"balance_after":38885,"source":{"system":"sec-edgar","filing":"0001641172-25-015207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000164117225015207/ownership.xml","form_type":"4"}},{"id":1112412,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-06-13T15:04:18.000Z","date":"2025-06-12","kind":"purchase","planned":false,"acquired":true,"shares":103,"price":8.7,"value":896.1,"ownership":{"direct":true},"balance_after":38675,"source":{"system":"sec-edgar","filing":"0001641172-25-015005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000164117225015005/ownership.xml","form_type":"4"}},{"id":1167331,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-04-23T20:35:17.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":1968504,"price":0.0254,"value":50000.0016,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025."}],"balance_after":3867533,"source":{"system":"sec-edgar","filing":"0001641172-25-005861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000164117225005861/ownership.xml","form_type":"4"}},{"id":1177013,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-04-07T19:42:56.000Z","date":"2025-04-04","kind":"purchase","planned":false,"acquired":true,"shares":41000,"price":0.063,"value":2583.0,"ownership":{"direct":true},"balance_after":1899029,"source":{"system":"sec-edgar","filing":"0001641172-25-002977","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000164117225002977/ownership.xml","form_type":"4"}},{"id":1220581,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-03-06T14:36:34.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.1346,"value":6730.0,"ownership":{"direct":true},"balance_after":1858029,"source":{"system":"sec-edgar","filing":"0001493152-25-009338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315225009338/ownership.xml","form_type":"4"}},{"id":1224148,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-03-05T15:00:05.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":44000,"price":0.115,"value":5060.0,"ownership":{"direct":true},"balance_after":1808029,"source":{"system":"sec-edgar","filing":"0001493152-25-009164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315225009164/ownership.xml","form_type":"4"}},{"id":1231799,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-03-04T18:14:26.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":83334,"price":0.12,"value":10000.08,"ownership":{"direct":true},"balance_after":1764029,"source":{"system":"sec-edgar","filing":"0001493152-25-009003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315225009003/ownership.xml","form_type":"4"}},{"id":1299109,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-01-21T21:32:14.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.212,"value":4240.0,"ownership":{"direct":true},"balance_after":1657968,"source":{"system":"sec-edgar","filing":"0001493152-25-003058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315225003058/ownership.xml","form_type":"4"}},{"id":1325770,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-12-19T18:38:10.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":true,"shares":22727,"price":0.206,"value":4681.762,"ownership":{"direct":true},"balance_after":1680695,"source":{"system":"sec-edgar","filing":"0001493152-24-050757","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224050757/ownership.xml","form_type":"4"}},{"id":1356187,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-11-21T17:04:11.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":85000,"price":0.199,"value":16915.0,"ownership":{"direct":true},"balance_after":1637968,"source":{"system":"sec-edgar","filing":"0001493152-24-047094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224047094/ownership.xml","form_type":"4"}},{"id":1357748,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-11-20T17:46:28.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":60110,"price":0.183,"value":11000.13,"ownership":{"direct":true},"balance_after":1552968,"source":{"system":"sec-edgar","filing":"0001493152-24-046952","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224046952/ownership.xml","form_type":"4"}},{"id":1405865,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-09-17T16:05:17.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.303,"value":1515.0,"ownership":{"direct":true},"balance_after":1493042,"source":{"system":"sec-edgar","filing":"0001493152-24-036837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224036837/ownership.xml","form_type":"4"}},{"id":1407089,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-09-16T19:45:11.000Z","date":"2024-09-13","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.308,"value":6160.0,"ownership":{"direct":true},"balance_after":1488042,"source":{"system":"sec-edgar","filing":"0001493152-24-036364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224036364/ownership.xml","form_type":"4"}},{"id":1409140,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-09-12T21:15:05.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":312500,"price":0.32,"value":100000.0,"ownership":{"direct":true},"balance_after":1468042,"source":{"system":"sec-edgar","filing":"0001493152-24-036076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224036076/ownership.xml","form_type":"4"}},{"id":1436312,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-08-13T01:39:11.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":377358,"price":0.265,"value":99999.87,"ownership":{"direct":true},"balance_after":1155542,"source":{"system":"sec-edgar","filing":"0001493152-24-031414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224031414/ownership.xml","form_type":"4"}},{"id":1525155,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-05-07T12:30:32.000Z","date":"2024-05-06","kind":"purchase","planned":false,"acquired":true,"shares":61729,"price":0.405,"value":25000.245,"ownership":{"direct":true},"balance_after":778184,"source":{"system":"sec-edgar","filing":"0001493152-24-018030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224018030/ownership.xml","form_type":"4"}},{"id":1559901,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Options","published_at":"2024-03-27T17:52:24.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":0.47,"exercise_date":"2024-11-30","expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-24-011463","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224011463/ownership.xml","form_type":"4"}},{"id":1573403,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-03-18T19:01:28.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":75758,"price":0.33,"value":25000.14,"ownership":{"direct":true},"balance_after":716455,"source":{"system":"sec-edgar","filing":"0001493152-24-010267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224010267/ownership.xml","form_type":"4"}},{"id":1729860,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-11-27T17:56:57.000Z","date":"2023-11-27","kind":"purchase","planned":false,"acquired":true,"shares":33861,"price":0.443,"value":15000.423,"ownership":{"direct":true},"balance_after":640697,"source":{"system":"sec-edgar","filing":"0001493152-23-042743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223042743/ownership.xml","form_type":"4"}},{"id":1771758,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-09-29T19:29:54.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":22676,"price":0.441,"value":10000.116,"ownership":{"direct":true},"balance_after":606836,"source":{"system":"sec-edgar","filing":"0001493152-23-034802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223034802/ownership.xml","form_type":"4"}},{"id":1796862,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-08-25T18:26:59.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":8222,"price":0.669,"value":5500.518,"ownership":{"direct":true},"balance_after":584160,"source":{"system":"sec-edgar","filing":"0001493152-23-030180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223030180/ownership.xml","form_type":"4"}},{"id":1798075,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-08-24T17:52:32.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":14993,"price":0.667,"value":10000.331,"ownership":{"direct":true},"balance_after":575938,"source":{"system":"sec-edgar","filing":"0001493152-23-030077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223030077/ownership.xml","form_type":"4"}},{"id":1828999,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-07-17T23:20:04.000Z","date":"2023-07-17","kind":"purchase","planned":false,"acquired":true,"shares":16950,"price":0.59,"value":10000.5,"ownership":{"direct":true},"balance_after":560945,"source":{"system":"sec-edgar","filing":"0001493152-23-024767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223024767/ownership.xml","form_type":"4"}},{"id":2069806,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-01-04T12:30:31.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":161291,"price":0.31,"value":50000.21,"ownership":{"direct":true},"balance_after":543995,"source":{"system":"sec-edgar","filing":"0001493152-23-000211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223000211/ownership.xml","form_type":"4"}},{"id":2098993,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Options","published_at":"2022-12-02T21:50:26.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options issued pursuant to employment agreement with Reporting Person."}],"balance_after":300000,"derivative":{"exercise_price":0.41,"exercise_date":"2023-11-30","expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-22-034332","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000149315222034332/ownership.xml","form_type":"4"}},{"id":2206482,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2022-07-18T19:01:20.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":32895,"price":0.76,"value":25000.2,"ownership":{"direct":true},"balance_after":382704,"source":{"system":"sec-edgar","filing":"0001450324-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032422000004/primary_doc.xml","form_type":"4"}},{"id":2290609,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2022-04-26T12:30:59.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":49020,"price":1.02,"value":50000.4,"ownership":{"direct":true},"balance_after":349809,"source":{"system":"sec-edgar","filing":"0001450324-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032422000002/primary_doc.xml","form_type":"4"}},{"id":2351377,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Options","published_at":"2022-03-04T15:06:58.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":0.7,"exercise_date":"2023-03-03","expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001702626-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000170262622000002/primary_doc.xml","form_type":"4"}},{"id":2476148,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-12-13T16:43:08.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":21552,"price":1.16,"value":25000.32,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Form amended to include reporting person is a director and officer."}],"balance_after":300789,"source":{"system":"sec-edgar","filing":"0001450324-21-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000013/primary_doc.xml","form_type":"4/A","original_submission_date":"2021-12-13"}},{"id":2476147,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2021-12-13T16:26:29.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":21552,"price":1.16,"value":25000.32,"ownership":{"direct":true},"balance_after":300789,"source":{"system":"sec-edgar","filing":"0001450324-21-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000012/primary_doc.xml","form_type":"4"}},{"id":2477740,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2021-12-10T15:55:01.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":11811,"price":1.27,"value":14999.97,"ownership":{"direct":true},"balance_after":279237,"source":{"system":"sec-edgar","filing":"0001450324-21-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000011/primary_doc.xml","form_type":"4"}},{"id":2496409,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-11-24T18:51:58.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":11627,"price":1.29,"value":14998.83,"ownership":{"direct":true},"balance_after":267426,"source":{"system":"sec-edgar","filing":"0001702626-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000170262621000002/primary_doc.xml","form_type":"4"}},{"id":2499281,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-11-23T16:08:37.000Z","date":"2021-11-23","kind":"grant","acquired":true,"shares":11194,"price":1.34,"value":14999.96,"ownership":{"direct":true},"balance_after":255799,"source":{"system":"sec-edgar","filing":"0001450324-21-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000009/primary_doc.xml","form_type":"4"}},{"id":2503507,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-11-19T16:28:59.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":10204,"price":1.47,"value":14999.88,"ownership":{"direct":true},"balance_after":244605,"source":{"system":"sec-edgar","filing":"0001450324-21-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000008/primary_doc.xml","form_type":"4"}},{"id":2508601,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-11-17T22:27:58.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":9146,"price":1.64,"value":14999.44,"ownership":{"direct":true},"balance_after":234401,"source":{"system":"sec-edgar","filing":"0001450324-21-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000007/primary_doc.xml","form_type":"4"}},{"id":2513622,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Options","published_at":"2021-11-15T21:57:48.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":1.71,"exercise_date":"2022-11-11","expiration_date":"2031-11-11","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001450324-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000004/primary_doc.xml","form_type":"4"}},{"id":2632483,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-07-16T16:07:32.000Z","date":"2021-07-16","kind":"purchase","acquired":true,"shares":15625,"price":1.92,"value":30000.0,"ownership":{"direct":true},"balance_after":225255,"source":{"system":"sec-edgar","filing":"0001450324-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000002/primary_doc.xml","form_type":"4"}},{"id":2836857,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-02-24T17:03:49.000Z","date":"2021-02-24","kind":"purchase","acquired":true,"shares":11062,"price":2.26,"value":25000.12,"ownership":{"direct":true},"balance_after":209630,"source":{"system":"sec-edgar","filing":"0001450324-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032421000001/primary_doc.xml","form_type":"4"}},{"id":2940889,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T17:22:09.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":14535,"price":1.72,"value":25000.2,"ownership":{"direct":true},"balance_after":198568,"source":{"system":"sec-edgar","filing":"0001450324-20-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032420000008/primary_doc.xml","form_type":"4"}},{"id":2981899,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Options","published_at":"2020-11-13T15:38:28.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":1.96,"exercise_date":"2021-11-11","expiration_date":"2030-11-11","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001450324-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032420000007/primary_doc.xml","form_type":"4"}},{"id":3040026,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2020-09-03T14:53:05.000Z","date":"2020-09-03","kind":"purchase","acquired":true,"shares":12316,"price":2.03,"value":25001.48,"ownership":{"direct":true},"balance_after":184033,"source":{"system":"sec-edgar","filing":"0001450324-20-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032420000006/primary_doc.xml","form_type":"4"}},{"id":3050275,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-08-21T12:08:07.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":10730,"price":2.33,"value":25000.9,"ownership":{"direct":true},"balance_after":171717,"source":{"system":"sec-edgar","filing":"0001450324-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032420000005/primary_doc.xml","form_type":"4"}},{"id":3057698,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Options","published_at":"2020-08-14T19:32:18.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":3.05,"exercise_date":"2021-08-12","expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001450324-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032420000004/primary_doc.xml","form_type":"4"}},{"id":3327857,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec.Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2020-01-02T15:47:52.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":14741,"price":0.53,"value":7812.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock Award. Vests in six months, provided continuous employment."}],"balance_after":160990,"source":{"system":"sec-edgar","filing":"0001450324-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032420000001/primary_doc.xml","form_type":"4"}},{"id":3341394,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec.Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-12-16T14:25:28.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":17960,"price":0.435,"value":7812.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock Award. Vests in six months, provided continuous employment."}],"balance_after":146249,"source":{"system":"sec-edgar","filing":"0001450324-19-000028","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000028/primary_doc.xml","form_type":"4"}},{"id":3356180,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec.Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-12-02T16:48:44.000Z","date":"2019-11-29","kind":"grant","acquired":true,"shares":19531,"price":0.4,"value":7812.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock Award. Vests in six months, provided continuous employment."}],"balance_after":128289,"source":{"system":"sec-edgar","filing":"0001450324-19-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000023/primary_doc.xml","form_type":"4"}},{"id":3369012,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec.Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-11-18T19:30:16.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":16622,"price":0.47,"value":7812.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock Award. Vests in six months, provided continuous employment."}],"balance_after":108758,"source":{"system":"sec-edgar","filing":"0001450324-19-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000018/primary_doc.xml","form_type":"4"}},{"id":3384746,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-10-31T15:36:33.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":15625,"price":0.5,"value":7812.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock Award. Vests in six months, provided continuous employment."}],"balance_after":92136,"source":{"system":"sec-edgar","filing":"0001450324-19-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000017/primary_doc.xml","form_type":"4"}},{"id":3392409,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-10-17T20:32:52.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":13470,"price":0.58,"value":7812.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock Award. Vests in six months, provided continuous employment."}],"balance_after":76511,"source":{"system":"sec-edgar","filing":"0001450324-19-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000013/primary_doc.xml","form_type":"4"}},{"id":3477450,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-06-27T19:32:27.000Z","date":"2019-06-27","kind":"purchase","acquired":true,"shares":2632,"price":4.37,"value":11501.84,"ownership":{"direct":true},"balance_after":63041,"source":{"system":"sec-edgar","filing":"0001450324-19-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000012/primary_doc.xml","form_type":"4"}},{"id":3479328,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-06-25T16:17:18.000Z","date":"2019-06-21","kind":"purchase","acquired":true,"shares":29404,"price":4.03,"value":118498.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of securities previously owned is being adjusted due to the 44 to 1 reverse stock split which occurred on June 11, 2019."}],"balance_after":60409,"source":{"system":"sec-edgar","filing":"0001702626-19-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000170262619000006/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-06-21"}},{"id":3481748,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-06-21T15:11:02.000Z","date":"2019-06-21","kind":"purchase","acquired":true,"shares":29404,"price":4.03,"value":118498.12,"ownership":{"direct":true},"balance_after":1393611,"source":{"system":"sec-edgar","filing":"0001450324-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000011/primary_doc.xml","form_type":"4"}},{"id":3488449,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-06-17T17:23:39.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":227500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Rights offering warrants using the cashless conversion feature , were converted into .70 number of shares."}],"balance_after":1364207,"source":{"system":"sec-edgar","filing":"0001613377-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337719000003/primary_doc.xml","form_type":"4"}},{"id":3488448,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-06-17T17:23:39.000Z","date":"2019-03-18","kind":"exercise","acquired":true,"shares":325000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the 65 shares issued."}],"balance_after":1136707,"source":{"system":"sec-edgar","filing":"0001613377-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337719000003/primary_doc.xml","form_type":"4"}},{"id":3588891,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2019-03-19T20:01:28.000Z","date":"2019-03-19","kind":"purchase","acquired":true,"shares":13400,"price":0.1755,"value":2351.7,"ownership":{"direct":true},"balance_after":811707,"source":{"system":"sec-edgar","filing":"0001450324-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000009/primary_doc.xml","form_type":"4"}},{"id":3600196,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Subr Rights(to buy)","published_at":"2019-03-12T20:29:55.000Z","date":"2019-02-27","kind":"other","acquired":true,"shares":65,"price":1000,"value":65000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 share of Series B Preferred Stock and 5,000 warrants."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2019-02-14","expiration_date":"2019-03-05","underlying":"Pref Stk/Warrants"},"source":{"system":"sec-edgar","filing":"0001450324-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000008/primary_doc.xml","form_type":"4"}},{"id":3600195,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Warrants","published_at":"2019-03-12T20:29:55.000Z","date":"2019-02-27","kind":"other","acquired":true,"shares":325000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 share of Series B Preferred Stock and 5,000 warrants."}],"balance_after":325000,"source":{"system":"sec-edgar","filing":"0001450324-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000008/primary_doc.xml","form_type":"4"}},{"id":3600194,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-03-12T20:29:55.000Z","date":"2019-02-27","kind":"other","acquired":true,"shares":65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 share of Series B Preferred Stock and 5,000 warrants."}],"balance_after":65,"source":{"system":"sec-edgar","filing":"0001450324-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000008/primary_doc.xml","form_type":"4"}},{"id":3682854,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2019-01-30T15:20:21.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":426136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued to senior management for a voluntary 50% deferral in salary."}],"balance_after":426136,"derivative":{"exercise_price":0.22,"exercise_date":"2019-01-28","expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":426136},"source":{"system":"sec-edgar","filing":"0001450324-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000001/primary_doc.xml","form_type":"4"}},{"id":3746598,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":6000,"price":0.196,"value":1176.0,"ownership":{"direct":true},"balance_after":798307,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746597,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":334,"price":0.1945,"value":64.963,"ownership":{"direct":true},"balance_after":792307,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746596,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":300,"price":0.1944,"value":58.32,"ownership":{"direct":true},"balance_after":791973,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746595,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":50,"price":0.1938,"value":9.69,"ownership":{"direct":true},"balance_after":791673,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746594,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":2400,"price":0.193,"value":463.2,"ownership":{"direct":true},"balance_after":791623,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746593,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":9557,"price":0.19,"value":1815.83,"ownership":{"direct":true},"balance_after":789223,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746592,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":5,"price":0.1892,"value":0.946,"ownership":{"direct":true},"balance_after":779666,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3746591,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-12-03T16:32:56.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":1354,"price":0.1891,"value":256.0414,"ownership":{"direct":true},"balance_after":779661,"source":{"system":"sec-edgar","filing":"0001450324-18-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000008/primary_doc.xml","form_type":"4"}},{"id":3749643,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-11-29T15:34:52.000Z","date":"2018-11-27","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019."}],"balance_after":778307,"source":{"system":"sec-edgar","filing":"0001613377-18-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000036/primary_doc.xml","form_type":"4"}},{"id":3762003,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-11-16T16:22:38.000Z","date":"2018-11-14","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option has been awarded by the Board of Directors."}],"balance_after":1000,"derivative":{"exercise_price":0.22,"exercise_date":"2018-11-14","expiration_date":"2028-11-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001613377-18-000029","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000029/primary_doc.xml","form_type":"4"}},{"id":3781827,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-10-29T13:14:15.000Z","date":"2018-10-26","kind":"purchase","acquired":true,"shares":3500,"price":0.203,"value":710.5,"ownership":{"direct":true},"balance_after":775807,"source":{"system":"sec-edgar","filing":"0001450324-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000007/primary_doc.xml","form_type":"4"}},{"id":3783525,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-10-25T13:22:49.000Z","date":"2018-10-25","kind":"purchase","acquired":true,"shares":100000,"price":0.2,"value":20000.0,"ownership":{"direct":true},"balance_after":772307,"source":{"system":"sec-edgar","filing":"0001450324-18-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000006/primary_doc.xml","form_type":"4"}},{"id":3787038,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-10-19T16:31:24.000Z","date":"2018-10-17","kind":"grant","acquired":true,"shares":284091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued to senior management in exchange for a voluntary 50% deferral in salary."}],"balance_after":284091,"derivative":{"exercise_price":0.22,"exercise_date":"2018-10-17","expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":284091},"source":{"system":"sec-edgar","filing":"0001613377-18-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000024/primary_doc.xml","form_type":"4"}},{"id":3860252,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-07-27T13:31:11.000Z","date":"2018-07-27","kind":"purchase","acquired":true,"shares":34483,"price":0.29,"value":10000.07,"ownership":{"direct":true},"balance_after":672306,"source":{"system":"sec-edgar","filing":"0001450324-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000005/primary_doc.xml","form_type":"4"}},{"id":3863110,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Common Stock","published_at":"2018-07-23T14:49:16.000Z","date":"2018-07-23","kind":"purchase","acquired":true,"shares":112904,"price":0.31,"value":35000.24,"ownership":{"direct":true},"balance_after":637823,"source":{"system":"sec-edgar","filing":"0001613377-18-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000020/primary_doc.xml","form_type":"4"}},{"id":3864822,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-07-19T18:41:24.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":161290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued to senior management in exchange for a voluntary 40% deferral in salary."}],"balance_after":161290,"derivative":{"exercise_price":0.31,"exercise_date":"2018-07-18","expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":161290},"source":{"system":"sec-edgar","filing":"0001450324-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000004/primary_doc.xml","form_type":"4"}},{"id":3926526,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-05-18T15:13:27.000Z","date":"2018-05-16","kind":"other","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock options issued per the employment agreement."}],"balance_after":795833,"derivative":{"exercise_price":0.3,"exercise_date":"2018-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001613377-18-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000009/primary_doc.xml","form_type":"4"}},{"id":3926525,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-05-18T15:13:27.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued to senior management in exchange for a voluntary 40% deferral in salary."}],"balance_after":250000,"derivative":{"exercise_price":0.3,"exercise_date":"2018-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001613377-18-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000009/primary_doc.xml","form_type":"4"}},{"id":3954034,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2018-04-30T10:22:37.000Z","date":"2018-04-27","kind":"purchase","acquired":true,"shares":32000,"price":0.32,"value":10240.0,"ownership":{"direct":true},"balance_after":524919,"source":{"system":"sec-edgar","filing":"0001450324-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032418000002/primary_doc.xml","form_type":"4"}},{"id":3960357,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"EQUELS THOMAS K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-04-19T19:01:03.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being awarded by the Board of Directors."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"exercise_date":"2018-04-12","expiration_date":"2028-04-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001465652-18-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000146565218000006/primary_doc.xml","form_type":"4"}},{"id":4025047,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice Chairman/CEO/Pres."}}],"security":"Options to buy Common Stock","published_at":"2018-03-01T20:12:34.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":371622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued by senior management in exchange for a voluntary 40% deferral in salary."}],"balance_after":371622,"derivative":{"exercise_price":0.37,"exercise_date":"2018-02-13","expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":371622},"source":{"system":"sec-edgar","filing":"0001191434-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000119143418000002/primary_doc.xml","form_type":"4"}},{"id":4220020,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-09-01T18:15:54.000Z","date":"2017-08-31","kind":"grant","acquired":true,"shares":24463,"price":0.26,"value":6360.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."}],"balance_after":24463,"derivative":{"exercise_price":0.36,"exercise_date":"2017-08-31","expiration_date":"2027-08-31","underlying":"Common Stock","underlying_shares":24463},"source":{"system":"sec-edgar","filing":"0001613377-17-000044","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000044/primary_doc.xml","form_type":"4"}},{"id":4233003,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-08-16T16:40:44.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":21336,"price":0.29,"value":6187.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."}],"balance_after":21336,"derivative":{"exercise_price":0.41,"exercise_date":"2017-08-15","expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":21336},"source":{"system":"sec-edgar","filing":"0001613377-17-000035","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000035/primary_doc.xml","form_type":"4"}},{"id":4247678,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-08-01T17:14:52.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":20786,"price":0.3,"value":6235.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."}],"balance_after":20786,"derivative":{"exercise_price":0.42,"exercise_date":"2017-07-31","expiration_date":"2027-07-31","underlying":"Common Stock","underlying_shares":20786},"source":{"system":"sec-edgar","filing":"0001613377-17-000030","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000030/primary_doc.xml","form_type":"4"}},{"id":4256610,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-07-17T20:24:46.000Z","date":"2017-07-15","kind":"grant","acquired":true,"shares":18124,"price":0.34,"value":6162.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."}],"balance_after":18124,"derivative":{"exercise_price":0.48,"exercise_date":"2017-07-15","expiration_date":"2027-07-15","underlying":"Common Stock","underlying_shares":18124},"source":{"system":"sec-edgar","filing":"0001613377-17-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000023/primary_doc.xml","form_type":"4"}},{"id":4265618,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-07-05T17:05:39.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":14214,"price":0.44,"value":6254.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."}],"balance_after":14214,"derivative":{"exercise_price":0.49,"exercise_date":"2017-06-30","expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":14214},"source":{"system":"sec-edgar","filing":"0001613377-17-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000017/primary_doc.xml","form_type":"4"}},{"id":4270530,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-06-29T17:49:29.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":14212,"price":0.44,"value":6253.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017."}],"balance_after":14212,"derivative":{"exercise_price":0.49,"exercise_date":"2017-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":14212},"source":{"system":"sec-edgar","filing":"0001613377-17-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000014/primary_doc.xml","form_type":"4/A","original_submission_date":"2017-06-19"}},{"id":4278019,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-06-19T20:51:56.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":14293,"price":0.44,"value":6288.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option is being issued in exchange for a voluntary 20% deduction in salary."}],"balance_after":14293,"derivative":{"exercise_price":0.54,"exercise_date":"2017-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":14293},"source":{"system":"sec-edgar","filing":"0001613377-17-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000010/primary_doc.xml","form_type":"4"}},{"id":4287537,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO / President"}}],"security":"Options to buy Common Stock","published_at":"2017-06-09T15:55:08.000Z","date":"2017-06-08","kind":"other","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock Options issued per the employment agreement."}],"balance_after":495833,"derivative":{"exercise_price":0.56,"exercise_date":"2017-06-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001450324-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032417000003/primary_doc.xml","form_type":"4"}},{"id":4343778,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2017-04-27T13:27:32.000Z","date":"2017-04-27","kind":"purchase","acquired":true,"shares":72464,"price":0.69,"value":50000.16,"ownership":{"direct":true},"balance_after":492919,"source":{"system":"sec-edgar","filing":"0001450324-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032417000002/primary_doc.xml","form_type":"4"}},{"id":4354739,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2017-04-11T13:54:55.000Z","date":"2017-04-11","kind":"purchase","acquired":true,"shares":200000,"price":0.5,"value":100000.0,"ownership":{"direct":true},"balance_after":420455,"source":{"system":"sec-edgar","filing":"0001450324-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032417000001/primary_doc.xml","form_type":"4"}},{"id":4512716,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2016-12-23T17:31:01.000Z","date":"2016-12-22","kind":"purchase","acquired":true,"shares":68493,"price":0.73,"value":49999.89,"ownership":{"direct":true},"balance_after":220455,"source":{"system":"sec-edgar","filing":"0001450324-16-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032416000016/primary_doc.xml","form_type":"4"}},{"id":4571160,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":60782,"kind":"person","name":"Equels Thomas K","position":1,"cik":"0001450324","reported_name":"Equels Thomas K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,President"}}],"security":"Common Stock","published_at":"2016-11-01T17:27:04.000Z","date":"2016-11-01","kind":"purchase","acquired":true,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":true},"balance_after":151962,"source":{"system":"sec-edgar","filing":"0001450324-16-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032416000015/primary_doc.xml","form_type":"4"}}]}